Nitric oxide therapy in sickle cell disease (Q34404477)

2 August 2017

1 reference

title

Nitric oxide therapy in sickle cell disease (English)

1 reference

2 August 2017

0 references

Gladwin MT

1

1 reference

PubMed ID

11605168

2 August 2017

Schechter AN

series ordinal

2

1 reference

2 August 2017

1 October 2001

1 reference

2 August 2017

Seminars in Hematology

1 reference

2 August 2017

38

1 reference

2 August 2017

4

1 reference

2 August 2017

333-342

1 reference

Inhaled nitric oxide in sickle cell disease with acute chest syndrome

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Renal nitric oxide synthases in transgenic sickle cell mice

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Ventilation and oxygenation induce endothelial nitric oxide synthase gene expression in the lungs of fetal lambs

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Clinical importance of coronary endothelial vasodilator dysfunction and therapeutic options

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Pathogenesis and treatment of sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Systemic fat embolism and pulmonary hypertension in sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Improvement in pulmonary hypertension and hypoxemia during nitric oxide inhalation in a patient with end-stage pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Pulmonary hypertension and cor pulmonale in the sickle hemoglobinopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Effect of anemia on intrapulmonary shunt during atelectasis in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Red-blood-cell augmentation of hypoxic pulmonary vasoconstriction: hematocrit dependence and the importance of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Nitric oxide synthesis in the lung. Regulation by oxygen through a kinetic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Effect of transfusion in acute chest syndrome of sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Nitrogen metabolism in sickle cell anemia: free amino acids in plasma and urine.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Nitric Oxide Protects Against Leukocyte-Endothelium Interactions in the Early Stages of Hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

The acute chest syndrome in sickle cell disease. Possible role of nitric oxide in its pathophysiology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Inhaled nitric oxide augments nitric oxide transport on sickle cell hemoglobin without affecting oxygen affinity

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Detection of nitrosyl hemoglobin in venous blood in the treatment of sickle cell anemia with hydroxyurea

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Hypoxic vasoconstriction in blood and plasma perfused lungs

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Effect of nitric oxide and nitric oxide donors on red blood cell oxygen transport

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

In vivo production of nitric oxide in rats after administration of hydroxyurea

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Time resolved absorption study of the reaction of hydroxyurea with sickle cell hemoglobin

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

The reaction of deoxy-sickle cell hemoglobin with hydroxyurea

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

EPR stopped-flow studies of the reaction of the tyrosyl radical of protein R2 from ribonucleotide reductase with hydroxyurea

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Sequential nitric oxide measurements during the emergency department treatment of acute vasoocclusive sickle cell crisis

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Nitric oxide metabolite levels in acute vaso-occlusive sickle-cell crisis

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Red blood cells play a crucial role in maintaining vascular reactivity to hypoxia in isolated rat lungs

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Arginine therapy: a novel strategy to induce nitric oxide production in sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Can we just say NO to sickle cell anemia?

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Sickle cell disease pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Levels of fetal hemoglobin necessary for treatment of sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Hydroxyurea reacts with heme proteins to generate nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Vascular endothelial cells synthesize nitric oxide from L-arginine

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Sickle cell anemia as an inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

The acute chest syndrome of sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Inhaled nitric oxide in primary pulmonary hypertension: a safe and effective agent for predicting response to nifedipine

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

The reactions of myoglobin, normal adult hemoglobin, sickle cell hemoglobin and hemin with hydroxyurea

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Levels of endothelial, neutrophil and platelet-specific factors in sickle cell anemia patients during hydroxyurea therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Nitric oxide generation from hydroxyurea via copper-catalyzed peroxidation and implications for pharmacological actions of hydroxyurea.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

A positive family history of premature coronary artery disease is associated with impaired endothelium-dependent coronary blood flow regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Sickle cell heart disease. Two-dimensional echo and Doppler ultrasonographic findings in the hearts of adult patients with sickle cell anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Nitric oxide attenuates normal and sickle red blood cell adherence to pulmonary endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Management of sickle cell disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

EPR studies on the oxidation of hydroxyurea to paramagnetic compounds by oxyhemoglobin

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Pulmonary hypertension in sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Exposure to shear stress alters endothelial adhesiveness. Role of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Fluid flow inhibits endothelial adhesiveness. Nitric oxide and transcriptional regulation of VCAM-1

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Acute chest syndrome in adult Afro-Caribbean patients with sickle cell disease. Analysis of 81 episodes among 53 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

Pulmonary hypertension and sickle hemoglobinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990027-7

7 January 2021

10.1016/S0037-1963(01)90027-7

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11605168